help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2002-0145
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/7/2775    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owen, D.
Right arrow Articles by Matthews, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owen, D.
Right arrow Articles by Matthews, S. G.
Endocrinology Vol. 144, No. 7 2775-2784
Copyright © 2003 by The Endocrine Society

Glucocorticoids and Sex-Dependent Development of Brain Glucocorticoid and Mineralocorticoid Receptors

Dawn Owen and Stephen G. Matthews

Departments of Physiology (D.O., S.G.M.), Obstetrics and Gynecology (S.G.M.), and Medicine (S.G.M.), Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 1A8

Address all correspondence and requests for reprints to: Dr. S. G. Matthews, Department of Physiology, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: stephen.matthews{at}utoronto.ca


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have previously shown that repeated antenatal synthetic glucocorticoid exposure has sex-specific effects on hypothalamic-pituitary-adrenal development in the fetal and adult guinea pig. However, little is known about the mechanisms that underlie these sex-specific outcomes. In the current study we demonstrated that glucocorticoid receptors (GR) and mineralocorticoid receptors (MR) exhibit sex differences in their temporal and spatial expression during fetal and early postnatal life. During development, we observed decreased GR mRNA in the paraventricular nucleus, decreased MR mRNA and MR protein in the hippocampus, and increased GR mRNA and GR protein in the hippocampus. We have also shown that on gestational d 50, maternally administered betamethasone (BETA) reduces fetal plasma ACTH and cortisol concentrations. BETA significantly affected hippocampal MR protein expression, and this effect was greatest in males. BETA was unable to autoregulate GR protein during fetal life, indicating that regulation of brain corticosteroid receptors is fundamentally different in fetal compared with adult life. The sex differences in the pattern of GR and MR expression during development may indicate different windows of vulnerability to prenatal glucocorticoid exposure in fetal life.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
EVENTS THAT disrupt maturation of the hypothalamic-pituitary-adrenal (HPA) axis, particularly its development in utero, have been shown to permanently alter corticosteroid receptor expression in the adult (1, 2, 3, 4). The fetal HPA axis is responsive to elevations of intrauterine glucocorticoids. This may occur as a result of maternal stress or after antenatal treatment with synthetic glucocorticoids (1, 2, 3, 4). The latter are administered under circumstances of suspected preterm labor and act to mature the fetal lungs. Both endogenous and synthetic glucocorticoids can cross the placenta from mother to fetus to affect fetal neuroendocrine development, especially in long gestation species (human, guinea pig, and sheep) that give birth to neuroanatomically mature young (5).

We have shown that repeated antenatal synthetic glucocorticoid (sGC) exposure has sex-specific effects on HPA development in the near-term fetal and adult guinea pig (6, 7). The guinea pig provides a model in which fetal brain development profiles approximate more closely those in the human than do profiles from other small animal species (5). Fetal neuroendocrine development in the guinea pig has also been shown to parallel that described in other species that give birth to mature young (8, 9). In the guinea pig, prenatal exposure to sGC modifies hippocampal mineralocorticoid receptor (MR) mRNA and glucocorticoid receptor (GR) mRNA levels in adult offspring (7). GR mRNA levels were reduced in the paraventricular nucleus (PVN), but were elevated in the hippocampus, in adult female offspring that had been exposed to sGC prenatally. In these animals, hippocampal MR mRNA levels were also significantly lower than control values. These changes resulted in adult female offspring that exhibited significantly increased basal and stimulated cortisol levels during the follicular phase of the reproductive cycle as well as significantly increased adrenal/body weight ratios (7). The changes are strongly supportive of a resetting of glucocorticoid negative feedback in these animals. In adult male offspring that had been exposed to sGC in utero, hippocampal MR mRNA levels were significantly elevated, suggestive of increased glucocorticoid negative feedback sensitivity. This was reflected by reduced basal and activated cortisol levels (7).

Although of considerable clinical importance, the mechanisms that underlie these sex-specific effects of repeated prenatal sGC exposure on subsequent HPA function are not known. Previous studies in the rat have focused on the postnatal ontogeny of brain GR and MR mRNA expression (10, 11, 12). Attempts to investigate the prenatal development of brain GR and MR in the rat are limited by its short gestation period (21 d) and its neurological immaturity at birth compared with that in the human and guinea pig (5). Although detected in the fetal human brain, virtually nothing is known about the developmental regulation of GR and MR. There is also little information on the relationship between corticosteroid receptor mRNA and the corresponding protein in development or the impact of prenatal sGC exposure on GR and MR protein levels. In the current study we hypothesized that 1) there are sex differences in prenatal development of the GR and MR systems in the fetal guinea pig brain; 2) there is a close association between mRNA and mature protein for corticosteroid receptors during late gestation and early postnatal life; and 3) prenatal treatment with sGC [betamethasone (BETA); which specifically activates GR] alters the expression pattern of MR and GR development in the fetal guinea pig brain in a sex-specific manner.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Female guinea pigs were mated in our animal facility as described previously (13). This method produces accurately time-dated pregnant guinea pigs. These studies were performed using protocols approved by the animal care committee at University of Toronto and in accordance with the Canadian Council for Animal Care. Pregnant guinea pigs were euthanized by decapitation, and fetuses were collected on gestational d (gd) 40, 50, and 64 (term = 68 d). One group of guinea pigs was allowed to deliver naturally, and neonates were euthanized by decapitation on postnatal d (pnd) 7. Trunk blood was collected, and the plasma was separated and stored at -20 C. We found no correlation between the order of fetal removal and plasma cortisol levels in previous studies (13). Fetal body and placental weights were recorded. Brains were removed and cut in half with the left hemisphere frozen for in situ hybridization. Hippocampi were dissected from the right hemispheres for Western blot analysis. All tissues were stored at -80 C until processing. The normal litter size is two or three fetuses; where possible, one male and one female fetus were taken from each litter for subsequent analysis.

Prenatal BETA treatment
Pregnant guinea pigs were sc injected with BETA (Betaject, Sabex, Boucherville, Canada; 1 mg/kg; 6 mg/ml) or vehicle (VEH; 166 µl/kg) on gd40/41 and 50/51. Animals were euthanized on gd52 by decapitation, and fetuses were collected. Trunk blood was collected, and fetal body and placental weights were recorded. Whole hippocampi were dissected from the right cerebral hemispheres and frozen. Hippocampi were stored at -80 C until processing for Western blot analysis.

In situ hybridization
The method for in situ hybridization has been described in detail previously (13). Coronal cryosections (10 µm) were mounted onto poly-L-lysine coated slides, dried, and fixed in paraformaldehyde (4%). Previously characterized oligonucleotide probes for GR and MR mRNA (8) were labeled using terminal deoxynucleotidyl transferase (Life Technologies, Inc., Burlington, Canada) and [35S]deoxy-ATP (1300 Ci/mmol; Perkin-Elmer, Woodbridge, Canada) to a specific activity of 1.0 x 109 cpm/µg. Labeled probe in hybridization buffer (200 µl) was applied to slides at a concentration of 1.0 x 103 cpm/µl. The antisense probes were complementary to bases 1–45 of the coding sequence of guinea pig GR mRNA and bases 2942–2986 of the coding sequence of human MR mRNA (14, 15); the guinea pig MR gene has not been sequenced. Slides were incubated overnight in a moist chamber at 42.5 C. After washing in 1x standard saline citrate (20 min at 23 C, then 35 min at 55 C), the slides were rinsed and dehydrated in ethanol. The slides were dried and exposed to autoradiographic film (Biomax MR, Kodak, Perkin-Elmer). Films were developed using an automatic processor (exposure: hippocampal, cortical, and paraventricular GR, 28 d; hippocampal and cortical MR, 14 d).

For in situ hybridization, brain sections were processed simultaneously to allow direct comparison between groups. The sections were exposed together with 14C-labeled standards (American Radiochemicals Inc., St. Louis, MO) to ensure analysis in the linear range of the autoradiographic film. The relative OD of the signal on autoradiographic film was quantified, after subtraction of background values, using a computerized image analysis system (Imaging Research, Inc., St. Catharines, Canada) (8, 13). Levels of GR mRNA expression were measured in the hippocampus (CA1/2, CA3, and CA4), dentate gyrus, lateral cerebral cortex, and hypothalamic PVN. MR mRNA levels were determined in the hippocampus (as for GR), dentate gyrus, and lateral cerebral cortex.

Western blot analysis
Hippocampi were homogenized in ice-cold RIPA lysis buffer [100–500 µl; 1% Triton X-100, 10% sodium dodecyl sulfate (vol/vol), 0.15 M NaCl, 15.4 mM Tris-HCl, 0.5% deoxycholic acid (wt/vol), 1 µM sodium orthovanadate, and Roche mini-EDTA-free protease inhibitor cocktail, pH 8.0]. The homogenate was centrifuged (4 C, 10,000 x g, 10 min), and the resulting supernatant was recentrifuged. The protein concentration of the resultant supernatant was determined by the Bradford method (16). Laemmli sample buffer (2x; 15 µl; Sigma-Aldrich Corp., Oakville, Canada) was added to each sample (50 µg protein), which was then denatured (boiled for 5 min at 95 C). Samples were separated by SDS-PAGE (8% resolving polyacrylamide gel) and transferred electrophoretically to a nitrocellulose membrane (Bio-Rad Laboratories, Inc., Mississauga, Canada).

Nitrocellulose membranes were blocked overnight (4 C) in skim milk (5%, wt/vol) PBS with Tween 20 (PBS-T). Membranes were washed with PBS-T and incubated with MR antibody (1:200; Santa Cruz Biotechnology, Inc., Santa Cruz, CA; H-300, sc-11412) in 5% skim milk PBS-T (1 h, 23 C). Membranes were then washed in PBS-T and incubated with horseradish peroxidase-conjugated goat antirabbit immunoglobulin G (1:1000; 1 h, 23 C; Perkin-Elmer). Blots were washed in PBS-T and exposed to Western Lightning Chemiluminescence Reagent Plus (Perkin-Elmer), and bands were visualized by exposure to Kodak Blue X-OMAT film for 5–30 sec (Perkin-Elmer). Films were developed by an automatic processor. Membranes were stripped in Restore Western Blot Stripping buffer (20 ml, 30 min, 23 C; Pierce Chemical Co., MJS Bioynx, Mississauga, Canada). The blots were blocked overnight in 5% skim milk PBS-T and incubated with an antibody specific for GR{alpha} (1:1000; Santa Cruz Biotechnology, Inc.; P-20, sc-1002) as described above. The absolute ODs of MR and GR were analyzed with computerized imaging software. All MR and GR signals were standardized to the signal for the ß-subunit of G protein (Gß; 1:5000; anti-Gß; Santa Cruz Biotechnology, Inc.; M-14, sc-261) or the signal for tubulin (1:5000; antitubulin; Sigma-Aldrich Corp.). The hippocampal expression of Gß did not vary between the ages that we measured, which was consistent with previous studies (17). However, we were concerned that the expression of Gß, a second messenger protein, may be influenced by synthetic glucocorticoids, so we used an alternate internal control (tubulin), in the VEH and BETA-treated animals. All Western blots were performed a minimum of four times for each animal. Data were pooled to derive a mean value for each animal. Expression levels are expressed as a ratio of GR or MR to Gß/tubulin signal. The small size and anatomical location of the hypothalamic PVN precluded parallel measurement of GR-ir and GR mRNA in this region.

Affinity labeling
Hippocampi were processed for affinity labeling according to the method of Weaver et al. (18). Briefly, hippocampi from gd64 animals were homogenized in ice-cold TEDGM buffer [100–250 µl; 30 mM Tris, 1 mM EDTA, 1 mM dithiothreitol, 10% (wt/vol) glycerol, 10 mM sodium molybdate, and Roche mini-EDTA-free protease inhibitor cocktail, pH 8.3]. The homogenate was centrifuged (100,000 x g, 30 min, 4 C), and the protein concentration was determined by the Bradford method (16). Supernatant (250 µl) was incubated overnight (4 C) with one of the following ligands: 1) 10 nM [3H]dexamethasone mesylate (American Radiochemicals, Inc., St. Louis, MO); 2) 10 nM [3H]dexamethasone mesylate and 100x GR-specific agonist RU28362 (M. J. Meaney, McGill University, Montreal, Canada); and 3) 10 nM [3H]dexamethasone mesylate and 100x unlabeled dexamethasone (Sigma-Aldrich Corp.). Incubates were run through LH-20 columns to remove unbound ligand. The eluate was concentrated by centrifugation (12,000 x g, 30 min, 4 C) in Millipore Ultrafree 0.5 ml centrifugal filters (NLMW 30,000, Fisher Scientific, Whitby, Canada) to a final volume of 15 µl. Concentrated eluate (1 µl, 2 µl) was adjusted to 15 µl with TEDGM buffer. Laemmli sample buffer (2x; 15 µl; Sigma-Aldrich Corp.) was added to concentrated and unconcentrated eluates. Samples were denatured (5 min at 95 C). Protein samples were separated by SDS-PAGE through an 8% resolving polyacrylamide gel. Gels were dehydrated in dimethylsulfoxide and incubated with 22% (wt/vol) 2,5-diphenyloxazole in dimethylsulfoxide (60 min, 23 C). The gels were washed with ultrapure water, dried using a vacuum gel drier at 65 C (Bio-Rad Laboratories, Inc.), and exposed to Kodak MS film (Perkin-Elmer) with a Kodak LE Transcreen (21 d, -70 C).

Alkaline phosphatase treatment
Hippocampi from gd64 animals were homogenized as described for Western blotting, but without sodium orthovanadate (phosphatase inhibitor). The hippocampal extracts were incubated with calf intestinal alkaline phosphatase (CIAP; 1000 U, 1 h, 37 C; Sigma-Aldrich Corp.). The protein concentration of incubates was determined by Bradford assay, and the incubates were dispensed into protein aliquots (50 µg) and frozen (-80 C) until analysis by Western blotting for GR protein as described above. Additionally, 1000 U CIAP were incubated in the presence of p-nitrophenyl phosphate (Sigma-Aldrich Corp.) to illustrate that the enzyme was functional.

Plasma ACTH and cortisol determination
Plasma cortisol and ACTH concentrations were measured using RIA kits (ICN Pharmaceuticals, Inc., Costa Mesa, CA) as previously described (6, 19). The ACTH antibody in this kit demonstrates 100% cross-reactivity with human ACTH1–24 and ACTH1–39 and less than 0.1% cross-reactivity with the smaller ACTH-related molecules. We have characterized this assay using guinea pig ACTH1–39 (Peninsula Laboratories, Inc., San Carlos, CA). Human ACTH1–39 and guinea pig ACTH1–39 provided identical standard curves using the assay kit. Cortisol is the predominant endogenous glucocorticoid in the guinea pig (20).

Statistical analysis
Group data are presented as the mean ± SEM and were statistically analyzed using ANOVA, followed by Duncan’s method of post hoc comparison (Statistica, Statsoft, Inc., Tulsa, OK). Statistical significance was set at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Plasma ACTH and cortisol concentrations: development
There was a significant overall effect of gestational age (time) on plasma ACTH levels before birth (P < 0.0001), but no significant difference between male and female fetuses. Plasma ACTH levels increased significantly from gd40 to gd50 in both sexes (P < 0.02; Fig. 1AGo) and remained unchanged between gd50 and gd64. Plasma ACTH concentrations decreased significantly after birth (term = 68 d) between gd64 and pnd7 (P < 0.01 for both sexes). There was a significant overall time effect on plasma cortisol concentration before birth (P < 0.0001; Fig. 1BGo). There was also a significant interaction between age and sex on plasma cortisol levels (P < 0.02). Plasma cortisol concentrations were low on gd40 and gd50, but increased dramatically between gd50 and gd64 (P < 0.0005 for both sexes; Fig. 1BGo). Plasma cortisol levels decreased significantly after birth between gd64 and pnd7 in males only (P < 0.0005). There was a sex difference in postnatal plasma cortisol levels, with males having significantly lower plasma cortisol levels than females (P < 0.008). The ratio of ACTH/cortisol (A:C) represents a crude index of adrenal sensitivity, with a lower ratio denoting higher sensitivity. There was a significant time effect on A:C during gestation (P < 0.002) as well as a significant interaction with sex for A:C (P < 0.03). A:C was low on gd40, but increased significantly between gd40 and gd50 (P < 0.0005; Fig. 1CGo) in both sexes, although males had a significantly lower ratio than females on gd50 (P < 0.002). A:C decreased dramatically between gd50 and gd64 (P < 0.0001), indicative of increased adrenal sensitivity. The A:C remained very low after birth.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. A, Plasma ACTH concentrations; B, plasma cortisol concentrations; C, A:C. {square}, Female fetuses and neonates; {blacksquare}, male fetuses and neonates. Data are expressed as the mean ± SEM. The broken line indicates term (~gd68). Numbers in each bar denote the number of animals in each group. Letters that are the same indicate significant differences (P < 0.05).

 
Hypothalamic GR expression: development
GR mRNA was highly expressed in the whole fetal PVN (total) on gd40 (Fig. 2AGo). In the PVN (total), GR mRNA levels decreased significantly between gd40 and gd64 in females only (P < 0.05), with levels remaining low postnatally (Table 1Go). There was a significant overall effect of age on total PVN expression of GR mRNA (P < 0.006). However, there were no sex differences in GR mRNA expression between gd40 and pnd7 in the PVN (Fig. 2BGo). In the medial parvocellular region of the PVN (mpPVN), GR mRNA levels decreased significantly with advancing gestation in male and female fetuses (P < 0.03; Fig. 2BGo). In both sexes, GR mRNA levels in the mpPVN were low at the end of gestation and postnatally. There was an overall effect of age on mpPVN GR mRNA levels (P < 0.0001), but no sex difference.



View larger version (65K):
[in this window]
[in a new window]
 
Figure 2. A, Representative illustration of GR mRNA levels in the PVN of gd40 and gd64 fetuses after in situ hybridization. B, GR mRNA levels in the mpPVN in female ({square}) and male ({blacksquare}) fetuses and neonates. Data are expressed as the mean relative OD (ROD) ± SEM. The broken line indicates term (~gd68). Numbers in each bar denote the number of animals in each group. Letters that are the same indicate significant differences (P < 0.05).

 

View this table:
[in this window]
[in a new window]
 
Table 1. GR mRNA levels in CA3, CA4 regions of the hippocampus, dentate gyrus (DG), total PVN, and cerebral cortex (Cerebral Cx) in female (F) and male (M) fetuses and neonates

 
Hippocampal GR expression: development
GR mRNA was present in the CA1–4 regions of the hippocampus and dentate gyrus, with highest levels in the hippocampal CA1/2 region (Fig. 3AGo). There was a significant overall age effect for CA1/2 GR mRNA levels (P < 0.0001; Fig. 3BGo), but no significant difference between sexes. GR mRNA levels increased significantly between gd40 and gd50 in both sexes (P < 0.001) in this hippocampal region, with levels remaining high to the end of gestation and postnatally. In the CA3 region, GR mRNA levels increased significantly between gd40 and gd50 in females only (P < 0.05), although there was a significant overall age effect (P < 0.04; Table 1Go). Similarly, in the CA4 region, GR mRNA expression increased significantly between gd40 and gd50 in females only (P < 0.05). In both sexes levels of GR mRNA remained unchanged after gd50 to the end of gestation and into the postnatal period (Table 1Go). Males showed no significant change in expression in CA4 at any age. In the dentate gyrus, GR mRNA levels increased significantly on gd64 in females only (P < 0.005) despite an overall age effect on GR mRNA expression in this region (P < 0.0005; Table 1Go). A significant increase in males was not observed until the postnatal period (P < 0.05; Table 1Go). There were no sex differences in GR mRNA expression in any of the regions examined.



View larger version (67K):
[in this window]
[in a new window]
 
Figure 3. A, Representative illustration of GR mRNA levels in the hippocampus of a gd40 fetus and a pnd7 neonate after in situ hybridization. B, GR mRNA levels in the CA1 region of the hippocampus in female ({square}) and male ({blacksquare}) fetuses and neonates. C, Hippocampal 95-kDa GR (active GR) protein in the fetus and neonate. Data are expressed as the mean relative OD (ROD) ± SEM. The broken line indicates term (~gd68). Numbers in each bar denote the number of animals in each group. Letters that are the same indicate significant differences (P < 0.05).

 
Western analysis revealed two specific GR bands that were close to the expected 94-kDa molecular mass of GR (14, 15, 18): 115 and 95 kDa (Fig. 4AGo). These were eliminated after preabsorption with the antigen peptide (Fig. 4AGo). The pattern of expression for the 95-kDa band correlated very closely with the GR mRNA levels in the CA1/2 region of the hippocampus, which represents the largest region in the hippocampus. However, GR protein expression lagged behind GR mRNA levels in both sexes (Fig. 3Go, B and C). Although GR mRNA levels were increased by gd50 in CA1/2, we did not observe an increase in GR protein (95-kDa band) until gd64 (P < 0.005; Fig. 3CGo). However, we could not pinpoint the length of this lag period, as there was a 14-d interval between our measurements on gd50 and gd64. As expected, there was a significant overall age effect on GR protein expression (P < 0.0001). The pattern of expression for the 115-kDa band did not correspond to that for the 95-kDa band or any of the GR mRNA profiles (data not shown). There were no sex differences in GR protein expression at any point in gestation.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 4. A, Representative Western blot for GR protein in fetal and neonatal hippocampi. B, Affinity labeling blot for GR protein in fetal (gd64) hippocampi. DM, Dexamethasone mesylate. C, Representative GR Western blot of CIAP-treated fetal hippocampal (gd64) homogenates.

 
Affinity labeling with [3H]dexamethasone mesylate established that only the 95-kDa band bound to ligand, and this binding was blocked by GR-specific agonists and excess cold ligand (Fig. 4BGo). Pretreatment with alkaline phosphatase demonstrated that the 115-kDa band is not a phosphorylated form of the 95-kDa GR protein. Preincubation did not change the migration distance in SDS-PAGE (Fig. 4CGo).

Hippocampal MR expression: development
Levels of MR mRNA were higher on gd40 than at any other time of late gestation or early postnatal life. MR mRNA decreased significantly between gd40 and gd50 in both sexes (P < 0.02) in the CA1/2 region, with levels remaining low to the end of gestation and into postnatal life (Fig. 5AGo). There was a significant overall age effect on CA1/2 MR mRNA expression (P < 0.0001). In the CA3 region, MR mRNA levels decreased between gd40 and gd50 for both sexes (P < 0.0005), with levels remaining low to the end of gestation and into postnatal life (Table 2Go). Overall, there was a significant decrease in MR mRNA expression for the CA3 region over time (P < 0.0001). In the CA4 region, MR mRNA decreased significantly on gd64 compared with gd50, but only in females (P < 0.03), with levels of expression unchanged postnatally (Table 2Go). No significant change in MR mRNA was observed in the CA4 region for male fetuses or neonates. MR mRNA levels in the dentate gyrus were unchanged throughout gestation and postnatally for both sexes (Table 2Go), although there was a significant interaction with sex (P < 0.05). There were no individual sex differences in MR mRNA expression in any of the other regions examined.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 5. A, MR mRNA levels in the CA1 region of the hippocampus. B, Hippocampal MR protein levels in female ({square}) and male ({blacksquare}) fetuses and neonates. Inset box, Representative Western blot for MR protein in fetal and neonatal hippocampi. Data are expressed as the mean ± SEM. The broken line indicates term (~gd68). Numbers in each bar denote the number of animals in each group. Letters that are the same indicate significant differences (P < 0.05).

 

View this table:
[in this window]
[in a new window]
 
Table 2. MR mRNA levels in CA3, CA4 regions of the hippocampus, dentate gyrus (DG), and cerebral cortex (Cerebral Cx) in female (F) and male (M) fetuses and neonates

 
Western analysis revealed a single MR band that approximated the expected 107-kDa molecular mass of MR (15): 111 kDa (Fig. 5BGo). The pattern of expression for the MR band correlated well with MR mRNA data from the CA1/2 and CA3 regions of the hippocampus. MR protein levels decreased significantly between gd40 and gd50, but only in males (P < 0.02; Fig. 5BGo). There was a significant age effect on MR protein expression (P < 0.0001), but no individual changes in MR protein expression were observed in females in late gestation. However, MR protein levels decreased significantly for both sexes after birth, between gd64 and pnd7 (P < 0.04). There were no sex differences in MR protein expression at any point in gestation.

Cortical GR and MR mRNA expression: development
No significant changes in either GR or MR mRNA levels were observed in the cerebral cortex in late gestation or postnatal life (Tables 1Go and 2Go, respectively). There were no sex differences in cortical GR and MR mRNA expression at any age of gestation.

Effect of prenatal betamethasone on fetal brain corticosteroid development
There was no significant effect of BETA treatment or sex on mean litter size (mean ± SEM: BETA, 3.4 ± 0.21 pups; VEH, 4.1 ± 0.37 pups), fetal body weight (BETA female, 36.25 ± 0.99 g; BETA male, 38.01 ± 0.79 g; VEH female, 37.21 ± 0.70 g; VEH male, 39.39 ± 1.42 g), placental weight (BETA female, 4.28 ± 0.18 g; BETA male, 4.31 ± 0.11 g; VEH female, 4.38 ± 0.15 g; VEH male, 4.58 ± 0.22 g), or brain weight (BETA female, 1.65 ± 0.02 g; BETA male, 1.67 ± 0.02 g; VEH female, 1.63 ± 0.02 g; VEH male, 1.66 ± 0.04 g). However, there were significant independent effects of treatment and sex on fetal brain/body weight ratio (BETA female, 0.0458 ± 0.0009; BETA male, 0.0442 ± 0.0009 g; VEH female, 0.0440 ± 0.0006 g; VEH male, 0.0423 ± 0.0008; P < 0.03 and P < 0.05, respectively). There was also a significant interaction with sex on fetal body weight (P < 0.04).

Repeated prenatal BETA exposure markedly suppressed both fetal plasma ACTH and cortisol concentrations on gd52 (P < 0.0005 for both ACTH and cortisol; Fig. 6Go, A and B). As expected, there was a very significant overall effect of treatment on both plasma ACTH and cortisol levels in these fetuses (P < 0.0001). Interestingly, male fetuses delivered from VEH-treated mothers exhibited a strong tendency for lower plasma cortisol than female fetuses (P = 0.055; Fig. 6BGo). There was an overall effect of treatment on A:C (P < 0.007; Fig. 6CGo). There was a significant decrease in A:C (P < 0.006) in BETA-exposed male fetuses compared with VEH males, but no similar effect in females. There was a significant effect of BETA treatment on MR protein expression by ANOVA (P < 0.03). There was also a tendency for MR protein to be down-regulated by prenatal BETA in males (P = 0.06; Table 3Go). BETA administration did not acutely alter GR protein expression on gd52 (Table 3Go).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 6. A, Plasma ACTH concentrations. B, Plasma cortisol concentrations. C, A:C. {square}, Female gd52 fetuses; {blacksquare}, male gd52 fetuses. Data are expressed as the mean ± SEM. Numbers in each bar denote the number of animals in each group. *, Significant difference from control group of same sex (P < 0.05).

 

View this table:
[in this window]
[in a new window]
 
Table 3. Hippocampal GR and MR protein expression in female (F) and male (M) gd52 fetuses treated with VEH or BETA

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In the current study, we have demonstrated that the development of GR and MR in the fetal brain undergoes spatial, temporal, and sex-specific regulation. These different expression profiles may underlie the sex-specific effects of prenatal GC exposure on HPA regulation in fetal, juvenile, and adult life (6, 7, 21). The late gestation rise in fetal ACTH and cortisol coincides with the increased adrenal sensitivity that is known to occur near term (3). In the fetal brain, GR mRNA levels decreased significantly in the PVN, reducing the potential for glucocorticoid negative feedback at this level of the HPA axis. Concomitantly, hippocampal GR expression increased significantly, whereas hippocampal MR levels decreased, the latter presumably releasing the axis from strong inhibitory tone (4). Further, we have established that hippocampal GR and MR mRNA and protein levels are closely correlated during fetal development, and that the fetal hippocampal GR can actively bind synthetic glucocorticoid. We have also shown that repeated exposure to prenatal BETA dramatically suppresses fetal plasma ACTH and cortisol in late gestation, and significantly alters A:C in a sex-specific manner. Hippocampal MR protein expression was decreased in BETA-treated animals, but there were no acute effects of BETA on hippocampal GR protein expression in either sex, thus demonstrating a failure of GR autoregulation in the fetal hippocampus.

The development of GR and MR in the fetal brain is critical for normal maturation of the brain as well as for activation of the fetal HPA axis and the initiation of parturition and organ maturation (3). Many species, including humans, guinea pigs, and sheep, experience a surge in plasma ACTH and cortisol in late gestation (3, 8, 20, 22, 23, 24, 25). This is important for the maturation of several organ systems, including lungs, kidneys, and brain (26, 27). In the current study we observed that plasma cortisol concentrations lagged behind a surge in plasma ACTH levels. This delay is probably a function of increased adrenal sensitivity. In this regard the responsiveness of the fetal guinea pig adrenal to ACTH injections in utero increases dramatically after gd45 (20). Similar increases in adrenal sensitivity have been reported in other species (3, 28, 29). In the fetal sheep, adrenal responsiveness is partly driven by ACTH, which up-regulates key steroidogenic enzymes, and by an increase in ACTH receptor expression (3, 30). There is also evidence for a modification of pituitary ACTH processing, such that levels of bioactive ACTH1–39 are increased in the late gestation fetal sheep (31). Similar changes probably account for increased adrenocortical activity the fetal guinea pig near term.

To sustain the elevated output of plasma cortisol and persistent activation of the HPA axis, negative feedback in the late gestation fetus is decreased. As expected, GR in the mpPVN decreased in the fetal guinea pig to reduce feedback on the axis; a similar trend has been reported in the fetal sheep near term (3). In the hippocampus, GR levels increased in parallel with a decrease in MR expression in late gestation. These changes are consistent with the model that activation of the hippocampal MR results in increased tonic inhibition of the HPA axis, while the hippocampal GR participates in facilitating activation of the HPA axis (4, 32, 33, 34). Thus, the complement of hippocampal corticosteroid receptors was shifted in favor of augmenting HPA output.

We also observed differential developmental patterns of GR and MR mRNA expression in the hippocampal subfields. GR mRNA levels in females increased in all hippocampal subfields before birth, whereas the only increase observed in males, other than in CA1/2, was an increase in the dentate gyrus during the postnatal period. In contrast, MR mRNA levels were decreased in CA1/2 and CA3 for both sexes with advancing gestation, but in CA4, MR mRNA was decreased only in female fetuses. These changes in MR mRNA are highly region specific, as there was no change in the dentate gyrus throughout gestation. In summary, female fetuses experience a greater increase in GR mRNA levels and a greater decrease in MR mRNA in the limbic system in late fetal/early embryonic life. This sex-specific pattern of hippocampal corticosteroid receptor mRNA development may underlie the elevated basal plasma cortisol observed in neonatal and adult female guinea pigs (7).

Although two previous studies have colocalized GR and MR mRNA with the corresponding receptor protein expression in the prenatal rat brain (35, 36), the present study is the first to have quantified the relative levels of mRNA and protein during development. There was very close correlation between MR and GR mRNA and corresponding protein in the hippocampal CA1/2 region. However, the increase in protein lagged behind the rise in mRNA. Unfortunately, the relatively long interval between sampling does not allow us to accurately determine the duration between changes in mRNA and protein.

Two GR-ir bands were revealed on Western blotting, but only the 95-kDa species bound to [3H]dexamethasone mesylate on affinity labeling, indicating that only this band represented a functional GR (18). The inability of the 115-kDa band to competitively bind the GR-specific ligand and an expression profile that did not match GR mRNA levels support this conclusion. When GR is bound to an agonist, there is receptor hyperphosphorylation, which can affect trans-activation activity, autoregulation of the receptor, and receptor half-life (37, 38). We initially hypothesized that the 115-kDa band may be phosphorylated and then targeted for ubiquitinylation and proteosome-mediated protein degradation (37). Further investigation of the 115-kDa band showed that it was not a phosphorylated form of the 95-kDa GR, providing further evidence that the 115-kDa band is not a modified form of the functional GR protein.

The rise in hippocampal GR expression in late gestation, when plasma cortisol concentrations are high, is somewhat counterintuitive, as in adults, increased endogenous GCs down-regulate the receptor in vivo and in vitro (39, 40, 41). However, recent studies indicate that ligand-bound MR may tonically inhibit GR biosynthesis in the hippocampus, possibly by binding to the glucocorticoid response element. There is evidence that spironolactone (MR antagonist) administration in adult rats increases GR mRNA expression in the CA1 region (39). Our results might be consistent with this model, as the rise in hippocampal GR mRNA is coincident with a very significant decline in hippocampal MR mRNA in the CA1 region. Perhaps decreased MR expression allows for elevated GR expression in the hippocampus. GR may also be less vulnerable to autoregulation, as it is relatively less occupied than the higher affinity MR in the basal HPA state (3).

The failure of fetal GR to autoregulate in the presence of high glucocorticoid concentrations may also be due to the immaturity of the autoregulatory machinery itself. GR ubiquitinylation and proteasomal degradation are a key pathway for the clearance of existing GR protein (38). The failure of GR to be ubiquitinylated and degraded decreases GR autoregulation and activates GR transcription (37). A recent study demonstrated that endogenous GR in primary hippocampal neurons derived from embryonic rats cannot be down-regulated because the GR degradation machinery is not fully functional in rat embryonic life (42). This is less likely in the guinea pig, as we have previously shown that sGC can reduce GR mRNA in late embryonic hippocampal neurons in this species (43) and because the guinea pig is so much more neurologically mature in late gestation than the rat.

Understanding the spatial and temporal development of GR and MR in the fetal brain provides insight into critical windows of vulnerability to exogenous prenatal glucocorticoid exposure. Synthetic glucocorticoids are routinely prescribed in women with threatened preterm birth in order to mature the fetal lungs (44, 45). Although a single course is recommended, recent surveys in Britain and Australia indicate that many obstetricians are prescribing multiple doses of glucocorticoids to treat threatened preterm birth (45, 46). Unfortunately, there is no evidence that multiple doses are more effective than a single dose regimen (47). In our laboratory we have demonstrated that repeated exposure to prenatal glucocorticoids permanently alters HPA function and brain corticosteroid receptor expression in adult life (6, 7). In the current study, we have shown that two courses of prenatal BETA dramatically suppresses fetal HPA function. There was a significant treatment effect on hippocampal MR protein expression, with the greatest effect in BETA-treated males. These results differ from previous findings where a similar, but extended, treatment regimen produced no significant treatment effect on either GR or MR mRNA on gd62. The acute effects of sGC on hippocampal MR protein observed in the present study may indicate time- and sex-dependent effects of prenatal glucocorticoid administration. BETA administration had no effect on hippocampal GR protein expression in either sex on gd52. This adds further evidence for failure of the normal GR autoregulatory machinery in the fetus.

In conclusion, the changes in corticosteroid receptor are consistent with and probably critically linked to activation of the fetal pituitary-adrenocortical system near term. In addition, GR and MR exhibit subtle sex differences in their temporal and spatial expression profiles during fetal and early postnatal life. These differences may account for the differences in adrenocortical activity in early postnatal life as well as the gender-specific differences in HPA function and behavior that have been reported in adult offspring after manipulation of the fetal environment. Fetal exposure to synthetic glucocorticoid significantly affected overall hippocampal MR protein expression, and this effect was greatest in males. Both endogenous and exogenous synthetic glucocorticoid fail to autoregulate GR expression in the fetus, indicating that regulation of brain corticosteroid receptors is fundamentally different in the fetus compared with that in adult life.


    Acknowledgments
 
We thank Drs. Bill Gibb, Ted Brown, Neil MacLusky, and Shelley Weaver for their help with the affinity labeling experiments, Dr. Michael Meaney for his gift of RU23862, and Ms. Lucy McCabe, Sonja Banjanin, and Alice Kostaki for their assistance with all of the experiments.


    Footnotes
 
This work was supported by the Canadian Institute for Health Research (Grant MOP-49511 to S.G.M. and M.D./Ph.D. Studentship to D.O.).

Abbreviations: A:C, Ratio of ACTH/cortisol; BETA, betamethasone; CIAP, calf intestinal alkaline phosphatase; gd, gestational day; Gß, ß-subunit of G protein; GR, glucocorticoid receptor; HPA, hypothalamic-pituitary-adrenal; mpPVN, medial parvocellular region of the paraventricular nucleus; MR, mineralocorticoid receptor; pnd, postnatal day; PBS-T, PBS with Tween 20; PVN, paraventricular nucleus; sGC, synthetic glucocorticoid; VEH, vehicle.

Received December 16, 2002.

Accepted for publication March 24, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Matthews SG 2000 Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 47:291–300[Medline]
  2. Welberg LA, Seckl JR 2001 Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13:113–128[CrossRef][Medline]
  3. Challis JRG, Matthews SG, Gibb W, Lye SJ 2000 Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:514–550[Abstract/Free Full Text]
  4. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269–301[Abstract/Free Full Text]
  5. Dobbing J, Sands J 1979 Comparative aspects of the brain growth spurt. Early Hum Dev 3:79–83[CrossRef][Medline]
  6. McCabe L, Marash D, Li A, Matthews SG 2001 Repeated antenatal glucocorticoid treatment decreases hypothalamic corticotropin releasing hormone mRNA but not corticosteroid receptor mRNA expression in the fetal guinea-pig brain. J Neuroendocrinol 13:425–431[CrossRef][Medline]
  7. Liu L, Li A, Matthews SG 2001 Maternal glucocorticoid treatment programs HPA regulation in adult offspring: sex-specific effects. Am J Physiol 280:E729–E739
  8. Matthews SG 1998 Dynamic changes in glucocorticoid and mineralocorticoid receptor mRNA in the developing guinea pig brain. Brain Res Dev Brain Res 107:123–132[Medline]
  9. Castro MI, Alex S, Young RA, Braverman LE, Emerson CH 1986 Total and free serum thyroid hormone concentrations in fetal and adult pregnant and nonpregnant guinea pigs. Endocrinology 118:533–537[Abstract]
  10. Meaney MJ, Sapolsky RM, McEwen BS 1985 The development of the glucocorticoid receptor system in the rat limbic brain. I. Ontogeny and autoregulation. Brain Res 350:159–164[Medline]
  11. Rosenfeld P, Sutanto W, Levine S, de Kloet ER 1988 Ontogeny of type I and type II corticosteroid receptors in the rat hippocampus. Brain Res 470:113–118[Medline]
  12. Bohn MC, Dean D, Hussain S, Giuliano R 1994 Development of mRNAs for glucocorticoid and mineralocorticoid receptors in rat hippocampus. Brain Res Dev Brain Res 77:157–162[Medline]
  13. Dean F, Matthews SG 1999 Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain. Brain Res 846:253–259[CrossRef][Medline]
  14. Keightley MC, Fuller PJ 1994 Unique sequences in the guinea pig glucocorticoid receptor induce constitutive transactivation and decrease steroid sensitivity. Mol Endocrinol 8:431–439[Abstract]
  15. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268–275[Abstract/Free Full Text]
  16. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  17. Kitamura Y, Mochii M, Kodama R, Agata K, Watanabe K, Eguchi G, Nomina Y 1989 Ontogenesis of {alpha}2 adrenoreceptor coupling with GTP-binding proteins in the rat telencephalon. J Neurochem 53:249–257[CrossRef][Medline]
  18. Weaver SA, Schaefer AL, Dixon WT 2000 Western blotting for detection of glucocorticoid receptors in the brain and pituitary gland from adrenal intact pigs. Brain Res 869:130–136[CrossRef][Medline]
  19. Akagi K, Challis JR 1990 Threshold of hormonal and biophysical responses to acute hypoxemia in fetal sheep at different gestational ages. Can J Physiol Pharmacol 68:549–555[Medline]
  20. Jones CT, Roebuck MM 1980 The development of the pituitary-adrenal axis in the guinea pig. Acta Endocrinol (Copenh) 94:107–116
  21. Dean F, Yu C, Lingas RI, Matthews SG 2001 Prenatal glucocorticoid modifies hypothalamo-pituitary-adrenal regulation in prepubertal guinea pigs. Neuroendocrinology 73:194–202[CrossRef][Medline]
  22. Challis JR, Brooks AN 1989 Maturation and activation of hypothalamic-pituitary adrenal function in fetal sheep. Endocr Rev 10:182–204[Abstract]
  23. Magyar DM, Fridshal D, Elsner CW, Glatz T, Eliot J, Klein AH, Lowe KC, Buster JE, Nathanielsz PW 1980 Time-trend analysis of plasma cortisol concentrations in the fetal sheep in relation to parturition. Endocrinology 107:155–159[Abstract]
  24. Jones CT, Lafeber HN, Roebuck MM 1984 Studies on the growth of the fetal guinea pig. Changes in plasma hormone concentration during normal and abnormal growth. J Dev Physiol 6:461–472[Medline]
  25. Dalle M, Delost P 1974 Changes in the concentrations of cortisol and corticosterone in the plasma and adrenal glands of the guinea-pig from birth to weaning. J Endocrinol 63:483–488[Medline]
  26. Liggins GC 1989 Can the benefits of antepartum corticosteroid treatment be improved? Eur J Obstet Gynecol Reprod Biol 33:25–30[CrossRef][Medline]
  27. Wright LL 1995 Effect of corticosteroids for fetal maturation and perinatal outcomes. Consensus Development Conference. February 28-March 2, 1994, Bethesda, Maryland. Am J Obstet Gynecol 173:253–262[CrossRef]
  28. Glickman JA, Challis JR 1980 The changing response pattern of sheep fetal adrenal cells throughout the course of gestation. Endocrinology 106:1371–1376[Medline]
  29. Challis JR, Manchester EL, Mitchell BF, Patrick JE 1982 Activation of adrenal function in fetal sheep by the infusion of adrenocorticotropin to the fetus in utero. Biol Reprod 27:1026–1032[Abstract]
  30. McDonald TJ, Hoffmann GE, Myers DA, Nathanielsz PW 1990 Hypothalamic glucocorticoid implants prevent fetal ovine adrenocorticotropin secretion in response to stress. Endocrinology 127:2862–2868[Abstract]
  31. McMillen IC, Merei JJ, White A, Crosby S, Schwartz J 1995 Increasing Gestational age and cortisol alter the ratio of ACTH precursors: ACTH secreted from the anterior pituitary of the fetal sheep. J Endocrinol 144:569–576[Abstract]
  32. Spencer RL, Kim PJ, Kalman BA, Cole MA 1998 Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 139:2718–2726[Abstract/Free Full Text]
  33. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N 1987 Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43:113–173
  34. Bradbury MJ, Akana SF, Cascio CS, Levin N, Jacobson L, Dallman MF 1991 Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J Steroid Biochem Mol Biol 40:133–142[CrossRef][Medline]
  35. Cintra A, Solfrini V, Bunnemann B, Okret S, Bortolotti F, Gustafsson JA, Fuxe K 1993 Prenatal development of glucocorticoid receptor gene expression and immunoreactivity in the rat brain and pituitary gland: a combined in situ hybridization and immunocytochemical analysis. Neuroendocrinology 57:1133–1147[Medline]
  36. Kitraki E, Alexis MN, Papalopoulou M, Stylianopoulou F 1996 Glucocorticoid receptor gene expression in the embryonic rat brain. Neuroendocrinology 63:305–317[CrossRef][Medline]
  37. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA 1997 Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272:9287–9293[Abstract/Free Full Text]
  38. Wallace AD, Cidlowski JA 2001 Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276:42714–42721[Abstract/Free Full Text]
  39. Herman JP, Spencer R 1998 Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J Neurosci 18:7462–7473[Abstract/Free Full Text]
  40. Oakley RH, Cidlowski JA 1993 Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 3:63–88[Medline]
  41. Sapolsky RM, McEwen BS 1985 Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone. Brain Res 339:161–165[CrossRef][Medline]
  42. Wang X, Pongrac JL, DeFranco DB 2002 Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity. Mol Endocrinol 16:1987–1998[Abstract/Free Full Text]
  43. Erdeljan P, MacDonald JF, Matthews SG, Do glucocorticoids and serotonin modify glucocorticoid and mineralocorticoid receptor mRNA levels in fetal guinea pig neurons, in vitro? Program of the 30th Annual Meeting of the Society for Neuroscience, Miami, FL 2000 (Abstract 152.3)
  44. NIH 2000 NIH Consensus statement: antenatal corticosteroids revisited: repeated courses, August 17–18, 2000. Obstet Gynecol 98:144–150
  45. Quinlivan JA, Evans SF, Dunlop SA, Beazley LD, Newnham JP 1998 Use of corticosteroids by Australian obstetricians: a survey of clinical practice. Aust NZ J Obstet Gynaecol 38:1–7[Medline]
  46. Brocklehurst P, Gates S, McKenzie-McHarg K, Alfirevic Z, Chamberlain G 1999 Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK. Br J Obstet Gynaecol 106:977–979[Medline]



This article has been cited by other articles:


Home page
J. Physiol.Home page
C. Bertram, O. Khan, S. Ohri, D. I. Phillips, S. G. Matthews, and M. A. Hanson
Transgenerational effects of prenatal nutrient restriction on cardiovascular and hypothalamic-pituitary-adrenal function
J. Physiol., April 15, 2008; 586(8): 2217 - 2229.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Setiawan, M. F. Jackson, J. F. MacDonald, and S. G. Matthews
Effects of repeated prenatal glucocorticoid exposure on long-term potentiation in the juvenile guinea-pig hippocampus
J. Physiol., June 15, 2007; 581(3): 1033 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S E Chadio, B Kotsampasi, G Papadomichelakis, S Deligeorgis, D Kalogiannis, I Menegatos, and G Zervas
Impact of maternal undernutrition on the hypothalamic-pituitary-adrenal axis responsiveness in sheep at different ages postnatal
J. Endocrinol., March 1, 2007; 192(3): 495 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Owen and S. G. Matthews
Repeated maternal glucocorticoid treatment affects activity and hippocampal NMDA receptor expression in juvenile guinea pigs
J. Physiol., January 1, 2007; 578(1): 249 - 257.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Catalano, T. Bruckner, A.R. Marks, and B. Eskenazi
Exogenous shocks to the human sex ratio: the case of September 11, 2001 in New York City
Hum. Reprod., December 1, 2006; 21(12): 3127 - 3131.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D S Gardner, B W M Van Bon, J Dandrea, P J Goddard, S F May, V Wilson, T Stephenson, and M E Symonds
Effect of periconceptional undernutrition and gender on hypothalamic-pituitary-adrenal axis function in young adult sheep.
J. Endocrinol., August 1, 2006; 190(2): 203 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Kapoor, E. Dunn, A. Kostaki, M. H. Andrews, and S. G. Matthews
Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids
J. Physiol., April 1, 2006; 572(1): 31 - 44.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Catalano and T. Bruckner
Secondary sex ratios and male lifespan: Damaged or culled cohorts
PNAS, January 31, 2006; 103(5): 1639 - 1643.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. Catalano, T. Bruckner, E. Anderson, and J. B Gould
Fetal death sex ratios: a test of the economic stress hypothesis
Int. J. Epidemiol., August 1, 2005; 34(4): 944 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Kapoor and S. G Matthews
Short periods of prenatal stress affect growth, behaviour and hypothalamo-pituitary-adrenal axis activity in male guinea pig offspring
J. Physiol., August 1, 2005; 566(3): 967 - 977.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Chan, K. Inouye, E. M. Akirav, E. Park, M. C. Riddell, S. G. Matthews, and M. Vranic
Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R235 - R246.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Catalano, T. Bruckner, J. Gould, B. Eskenazi, and E. Anderson
Sex ratios in California following the terrorist attacks of September 11, 2001
Hum. Reprod., May 1, 2005; 20(5): 1221 - 1227.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Setiawan, D. Owen, L. McCabe, A. Kostaki, M. H. Andrews, and S. G. Matthews
Glucocorticoids Do Not Alter Developmental Expression of Hippocampal or Pituitary Steroid Receptor Coactivator-1 and -2 in the Late Gestation Fetal Guinea Pig
Endocrinology, August 1, 2004; 145(8): 3796 - 3803.
[Abstract] [Full Text]